Aberrant expression of cell-cycle regulator cyclin DI in breast cancer is related to chromosomal genomic instability

Jia Chyi Lung, Jan Show Chu, Jyh Cherng Yu, Chung Tai Yue, Yen Li Lo, Chen Yang Shen, Cheng Wen Wu

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

To account for the accumulation of genomic alterations required for tumor progression, it has been suggested that the genomes of cancer cells are unstable and that this instability results from defective mutators (the "mutator phenotype" theory). To examine the hypothesis that abnormal cell-cycle regulators act as the mutators contributing to genomic instability, the present study, based on primary tumor tissues from 71 patients with breast cancer, was performed to determine whether there was an association between aberrant expression of cell-cycle regulators (cyclin A, cyclin DI, cyclin E, RBI, p21, and p27) and chromosomal instability. Comparative genomic hybridization was used to measure chromosomal changes, reflecting genomic instability in individual tumors, whereas immunohistochemistry was used to detect aberrant expression of cell-cycle regulators. Overexpression of cyclin DI was found to be significantly correlated with increased chromosomal instability (defined as harboring more than 7 chromosomal changes), with 63% of tumors overexpressing and 27% of tumors not overexpressing, with cyclin DI showing chromosomal instability (P <0.05). Interestingly, this relationship was independent of cell outgrowth (as detected by the proliferation marker Ki-67) and was particularly significant in tumors not expressing p27 or in tumors with detectable RBI. These results suggest that cyclin DI plays an alternative role in the regulation of genomic stability.

Original languageEnglish
Pages (from-to)276-284
Number of pages9
JournalGenes Chromosomes and Cancer
Volume34
Issue number3
DOIs
Publication statusPublished - 2002

Fingerprint

Chromosomal Instability
Cyclins
Genomic Instability
Cell Cycle
Breast Neoplasms
Neoplasms
Cyclin A
Cyclin E
Comparative Genomic Hybridization
Immunohistochemistry
Genome
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Aberrant expression of cell-cycle regulator cyclin DI in breast cancer is related to chromosomal genomic instability. / Lung, Jia Chyi; Chu, Jan Show; Yu, Jyh Cherng; Yue, Chung Tai; Lo, Yen Li; Shen, Chen Yang; Wu, Cheng Wen.

In: Genes Chromosomes and Cancer, Vol. 34, No. 3, 2002, p. 276-284.

Research output: Contribution to journalArticle

Lung, Jia Chyi ; Chu, Jan Show ; Yu, Jyh Cherng ; Yue, Chung Tai ; Lo, Yen Li ; Shen, Chen Yang ; Wu, Cheng Wen. / Aberrant expression of cell-cycle regulator cyclin DI in breast cancer is related to chromosomal genomic instability. In: Genes Chromosomes and Cancer. 2002 ; Vol. 34, No. 3. pp. 276-284.
@article{20452470a9364d309435fc21e5efdb32,
title = "Aberrant expression of cell-cycle regulator cyclin DI in breast cancer is related to chromosomal genomic instability",
abstract = "To account for the accumulation of genomic alterations required for tumor progression, it has been suggested that the genomes of cancer cells are unstable and that this instability results from defective mutators (the {"}mutator phenotype{"} theory). To examine the hypothesis that abnormal cell-cycle regulators act as the mutators contributing to genomic instability, the present study, based on primary tumor tissues from 71 patients with breast cancer, was performed to determine whether there was an association between aberrant expression of cell-cycle regulators (cyclin A, cyclin DI, cyclin E, RBI, p21, and p27) and chromosomal instability. Comparative genomic hybridization was used to measure chromosomal changes, reflecting genomic instability in individual tumors, whereas immunohistochemistry was used to detect aberrant expression of cell-cycle regulators. Overexpression of cyclin DI was found to be significantly correlated with increased chromosomal instability (defined as harboring more than 7 chromosomal changes), with 63{\%} of tumors overexpressing and 27{\%} of tumors not overexpressing, with cyclin DI showing chromosomal instability (P <0.05). Interestingly, this relationship was independent of cell outgrowth (as detected by the proliferation marker Ki-67) and was particularly significant in tumors not expressing p27 or in tumors with detectable RBI. These results suggest that cyclin DI plays an alternative role in the regulation of genomic stability.",
author = "Lung, {Jia Chyi} and Chu, {Jan Show} and Yu, {Jyh Cherng} and Yue, {Chung Tai} and Lo, {Yen Li} and Shen, {Chen Yang} and Wu, {Cheng Wen}",
year = "2002",
doi = "10.1002/gcc.10072",
language = "English",
volume = "34",
pages = "276--284",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Aberrant expression of cell-cycle regulator cyclin DI in breast cancer is related to chromosomal genomic instability

AU - Lung, Jia Chyi

AU - Chu, Jan Show

AU - Yu, Jyh Cherng

AU - Yue, Chung Tai

AU - Lo, Yen Li

AU - Shen, Chen Yang

AU - Wu, Cheng Wen

PY - 2002

Y1 - 2002

N2 - To account for the accumulation of genomic alterations required for tumor progression, it has been suggested that the genomes of cancer cells are unstable and that this instability results from defective mutators (the "mutator phenotype" theory). To examine the hypothesis that abnormal cell-cycle regulators act as the mutators contributing to genomic instability, the present study, based on primary tumor tissues from 71 patients with breast cancer, was performed to determine whether there was an association between aberrant expression of cell-cycle regulators (cyclin A, cyclin DI, cyclin E, RBI, p21, and p27) and chromosomal instability. Comparative genomic hybridization was used to measure chromosomal changes, reflecting genomic instability in individual tumors, whereas immunohistochemistry was used to detect aberrant expression of cell-cycle regulators. Overexpression of cyclin DI was found to be significantly correlated with increased chromosomal instability (defined as harboring more than 7 chromosomal changes), with 63% of tumors overexpressing and 27% of tumors not overexpressing, with cyclin DI showing chromosomal instability (P <0.05). Interestingly, this relationship was independent of cell outgrowth (as detected by the proliferation marker Ki-67) and was particularly significant in tumors not expressing p27 or in tumors with detectable RBI. These results suggest that cyclin DI plays an alternative role in the regulation of genomic stability.

AB - To account for the accumulation of genomic alterations required for tumor progression, it has been suggested that the genomes of cancer cells are unstable and that this instability results from defective mutators (the "mutator phenotype" theory). To examine the hypothesis that abnormal cell-cycle regulators act as the mutators contributing to genomic instability, the present study, based on primary tumor tissues from 71 patients with breast cancer, was performed to determine whether there was an association between aberrant expression of cell-cycle regulators (cyclin A, cyclin DI, cyclin E, RBI, p21, and p27) and chromosomal instability. Comparative genomic hybridization was used to measure chromosomal changes, reflecting genomic instability in individual tumors, whereas immunohistochemistry was used to detect aberrant expression of cell-cycle regulators. Overexpression of cyclin DI was found to be significantly correlated with increased chromosomal instability (defined as harboring more than 7 chromosomal changes), with 63% of tumors overexpressing and 27% of tumors not overexpressing, with cyclin DI showing chromosomal instability (P <0.05). Interestingly, this relationship was independent of cell outgrowth (as detected by the proliferation marker Ki-67) and was particularly significant in tumors not expressing p27 or in tumors with detectable RBI. These results suggest that cyclin DI plays an alternative role in the regulation of genomic stability.

UR - http://www.scopus.com/inward/record.url?scp=0036107422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036107422&partnerID=8YFLogxK

U2 - 10.1002/gcc.10072

DO - 10.1002/gcc.10072

M3 - Article

C2 - 12007188

AN - SCOPUS:0036107422

VL - 34

SP - 276

EP - 284

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 3

ER -